2004 Adopted Resolutions
72nd Annual Meeting
Boston

return to table of contents

IN SUPPORT OF ADEQUATELY SUPPLYING THE STRATEGIC NATIONAL STOCKPILE WITH ANTHRAX VACCINE

     WHEREAS, the United States of America needs to have an adequate stockpile of biological vaccines.  This includes the only approved and tested anthrax vaccine, while the next generation of biological vaccines are being proposed, developed, and tested, the United States of America needs to have an adequate supply of approved and proven biological vaccines, this includes the only approved anthrax vaccine; and

     WHEREAS, while the Department of Defense has effectively and actively immunized more than one million soldiers over the last five years from anthrax, with the only approved vaccine; and

     WHEREAS, if there is an anthrax attack today in the United States, the American people and our first responders need to be prepared.  Our cities, states, and nation need adequate stockpiles of anthrax vaccine today; and

     WHEREAS, the next generation of anthrax vaccines may not be tested and approved for another five years; and

     WHEREAS, the recent setbacks in the next generation smallpox program should highlight the need for the Department of Health and Human Services (DHHS) to reevaluate its decisions regarding anthrax.  Though millions of dollars have been invested in the next generation smallpox, this product may never be useable by the Strategic National Stockpile because of its side effects.  We may be headed in that same direction with the next generation of anthrax vaccines; and

     WHEREAS, if there were an anthrax attack today involving multiple urban areas we would not have enough vaccine to treat our citizens in accordance with CDC recommendations, which call for three doses of anthrax vaccine and antibiotics; and

     WHEREAS, the DHHS is putting all its efforts in one experimental and untested vaccine; and

     WHEREAS, the DHHS has plans to stockpile only a small amount of the current and approved anthrax vaccine to date, and appears to have no plans to stockpile more than a minimum level of the current FDA approved vaccine to prevent anthrax,

     NOW, THEREFORE, BE IT RESOLVED that The United States Conference of Mayors urges Secretary Tommy Thompson to increase the level of the FDA approved and tested anthrax vaccine into the Strategic National Stockpile without delay; and

     BE IT FURTHER RESOLVED that The United States Conference of Mayors calls on all its members to take all necessary steps to protect the country’s cities over the next five years while the next generation vaccines are being developed and approved by the FDA.